EFM
DYN icon

E Fund Management’s Dyne Therapeutics DYN Stock Holding History

E Fund Management’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$360K Sell
16,230
-6,771
-29% -$126K 0.01% 351
2026
Q1 		$417K Buy
+23,001
New +$397K 0.01% 325
2025
Q2 		$117K Sell
12,274
-1,497
-11% -$16.5K 0.01% 373
2025
Q1 		$144K Buy
13,771
+1,923
+16% +$27.5K 0.01% 373
2024
Q4 		$279K Buy
11,848
+1,249
+12% +$36.9K 0.01% 326
2024
Q3 		$381K Buy
10,599
+1,770
+20% +$70.4K 0.02% 228
2024
Q2 		$312K Sell
8,829
-7,446
-46% -$216K 0.02% 226
2024
Q1 		$462K Buy
+16,275
New +$368K 0.03% 168

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

E Fund Management's DYN Position: Q2 2026 in Review

E Fund Management reduced its Dyne Therapeutics (DYN) stake by 29% in Q2 2026, selling an estimated $126K and leaving 16,230 shares worth $360K. The position accounts for 0.01% of the portfolio, ranked #351.

E Fund Management first reported a position in DYN in Q1 2024 and has held it in 8 quarters since. The position peaked at $462K in Q1 2024. 246 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • E Fund Management held 16,230 shares of Dyne Therapeutics worth $360K as of Q2 2026.
  • E Fund Management sold 6,771 Dyne Therapeutics shares in Q2 2026, an estimated $126K.
  • Dyne Therapeutics made up 0.01% of E Fund Management's portfolio in Q2 2026, its #351 holding.
  • E Fund Management first reported a position in Dyne Therapeutics in Q1 2024 and has held it in 8 quarters since.
  • E Fund Management's Dyne Therapeutics position peaked at $462K in Q1 2024.
  • 246 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.